Inflammatory model in patients with primary open angle glaucoma and diabetes

Area of Science:

• Ophthalmology
• Immunology
• Endocrinology

Background:

• Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
• Diabetes mellitus is increasingly recognized as a risk factor and potential modifier for glaucoma.
• Understanding the inflammatory mechanisms in diabetic POAG is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression of inflammatory cytokines in the aqueous humor of patients with diabetic POAG.
• To identify specific inflammatory markers that differentiate between POAG, diabetes, and diabetic POAG.
• To explore the predictive value of these markers for disease severity.

Main Methods:

• A cross-sectional study involving 87 eyes across four groups: diabetic patients, POAG patients, diabetic POAG patients, and healthy controls.
• Aqueous humor samples were analyzed for 21 inflammatory markers using Luminex® cytometric bead assay.
• Demographic data, intraocular pressure (IOP), and treatment details were recorded for correlation and prediction analyses.

Main Results:

• Significant differences in cytokine expression were observed, particularly for CXCL5, CXCL8, IL-1α, IL-2, CCL4, CCL5, and TNFα.
• CXCL5 and IL-2 were identified as key "separation markers" distinguishing POAG from diabetic POAG.
• While these markers predicted TNFα levels in POAG, their predictive power was limited in diabetic and diabetic POAG patients.

Conclusions:

• An inflammatory model involving elevated TNFα is implicated in POAG.
• The inflammatory profile in diabetic POAG is complex, with co-stimulatory molecules and additional pathways requiring further investigation.
• Current predictive models partially explain elevated TNFα in diabetic POAG, highlighting the need for more comprehensive research.